International Space University Partners with Metavisionaries to Bring Space Science to Metaverse
5.7.2022 14:33:00 EEST | Business Wire | Press release
In the 34th Edition of the Space Studies Program, the International Space University will be entering the metaverse for the first time with the Metavisionaries in the ‘Metaship’ for an onsite lecture in the metaverse titled ‘How the human body functions in the unique environment of space’.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220705005411/en/
metavisionaries.io (Graphic: AETOSWire)
This event will be led by space scientists Tara Ruttley, Metavisionaries’ Director of Sciences (former associate chief scientist at NASA), and James Green, ISU’s Core Co-Chair, & former Chief Scientist of NASA. They will guide participants through a hands-on activity in Técnico Superior Técnico, Portugal, where SSP is taking place.
Metavisionaries aims to bring access to the space economy and frontier technologies through web3 to democratize education and provide global, interdisciplinary, and immersive learning opportunities to learners around the globe.
This is the beginning of a partnership that will gather educators, scientists, and industry experts to deliver interdisciplinary curricula and prepare students for the future of work, which is closely aligned with SSP’s philosophy. The SSP is an intensive two-month program hosted every year. It offers participants a unique and comprehensive professional development experience, covering all aspects of space programs and enterprises.
Wasim Ahmed, CEO for Metavisionaries, explained that the pandemic accelerated the rate of technology adoption in the education sector. Web 3.0 and the Metaverse are paving the way for education to be reimagined. In that sense, the partnership with ISU showcases the university's determination to play a leading role in shaping and enabling the transformation to prepare future generations for the future of work.
This immersive activity will allow the ISU to enter the world of the metaverse and provide learning in a way that participants have never experienced before. Following this activity ISU, Metavisionaries & Ice Cubes will share more details about joining the College of Business and Economics at Qatar University to launch a global business sustainability space challenge related to the FIFA World Cup.
Watch ISU in Metaverse on 5th July, 2022 11am Lisbon, Portugal time on: https://youtu.be/KtJCZN-5Ll0
For sponsorship package: https://drive.google.com/file/d/1JsFLK0BtNaaEWdUnGLZIfOKFeNC-5s-z/view?usp=drivesdk
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220705005411/en/
Contact information
Wasim Ahmed, 0033689790118
wasim@metavisionaries.io
Marcia Alvarenga,
marcia.alvarenga@live.isunet.edu
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 08:00:00 EEST | Press release
Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom